CompletedNot Applicable

The Neuromarker S-100B in Patients With Different Types of Intracranial Injury

Austria1,800 participantsStarted 2012-05

Plain-language summary

Abstract: The most widely studied neuro-markers in traumatic brain injury (TBI) are S100B and neurone specific enolase (NSE). S-100B is localized in astroglia. This marker is used to predict neuronal damage caused by traumatic brain injury. The investigators conduct a study to derive and validate the measurement of S-100B in serum of patients with different types traumatic brain injuries.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all patients with traumatic brain injury Exclusion Criteria: * patients without traumatic brain injury

What they're measuring

S100B LEVEL

Timeframe: 14 month

Trial details

NCT IDNCT01619293

SponsorMedical University of Vienna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-11

View on ClinicalTrials.gov More Traumatic Brain Injury trials